Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.

Circulation. Heart failure - 1 Sept 2013

Dadu Razvan T, Dodge Rhiannon, Nambi Vijay, Virani Salim S, Hoogeveen Ron C, Smith Nicholas L, Chen Fengju, Pankow James S, Guild Cameron, Tang W H Wilson, Boerwinkle Eric, Hazen Stanley L, Ballantyne Christie M

Abstract excerpt

BACKGROUND: Ceruloplasmin (Cp) decreases nitric oxide bioavailability in blood and has been associated with cardiovascular disease (CVD) in clinical studies. We assessed the associations between Cp and incident heart failure (HF), death, and CVD in the Atherosclerosis Risk in Communities (ARIC) study. METHODS AND RESULTS: Cp was measured at ARIC visit 4 (1996-1998). We studied 9240 individuals without HF or CVD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Ceruloplasmin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 3

Share to Disease-Free Survival

Share to Estrogen Replacement Therapy

Share to Heart Failure

Share to Linear Models

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 23861484
DOI: 10.1161/CIRCHEARTFAILURE.113.000270
PMCID: PMC3908901

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.PMID 23861484Read ↗

Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.Semantic proximity Read ↗

Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.Semantic proximity Read ↗

Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.Semantic proximity Read ↗

HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.Semantic proximity Read ↗

Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study.Semantic proximity Read ↗

Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study.Semantic proximity Read ↗

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly.Semantic proximity Read ↗

Circulating and dietary α-linolenic acid and incidence of congestive heart failure in older adults: the Cardiovascular Health Study.Semantic proximity Read ↗

Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.